The Greens have released the costings of their plan to legalise and tax cannabis in Australia.

The proposal also outlines the production and sale of recreational cannabis in Australia through a tightly regulated model, including establishing a new agency, the Australian Cannabis Agency, to act as the sole wholesaler between producers and retail outlets.

It would also set prices and be responsible for issuing production and sales licences.

There are about 25 cannabis-related stocks trading on the ASX, though most are focused on medical or cosmetic applications.

Here’s Stockhead’s list of which stocks hold Australian cannabis licences.

Scroll down for a full list of ASX pot stocks.

Costings from the federal Parliamentary Budget Office says legalising marijuana in Australia would increase the fiscal balance by $3.5 billion and increase the underlying cash balance by $3.3 billion over the Budget forward estimates period.

Taxes would lead to a surge in revenue of over $4.5 billion, with costs running at just over $1 billion.

Among other aspects of the proposal which would see sales of recreational cannabis restricted to individuals over 18 years of age, with no restrictions on the amount individuals could purchase, it assumes the average recreational cannabis consumer purchases three grams per week.

With the average joint containing approximately 0.32 grams of cannabis, that’s enough marijuana to make about 10 joints a week.

While that sounds like a lot, the plan put forward by the Greens is based on analysis of countries and states where legalisation of recreational cannabis has occurred, and acknowledges that the actual outcomes may differ significantly due to differences in policy specifications and market characteristics between Australia and overseas.

Also under the proposal, sales to overseas visitors would be permitted and individuals would be permitted to grow up to six plants for personal use.

Here is a list of ASX pot stocks:

ASX CodeName3-month price change (Jan-Mar)Market Cap (end of Mar)
ZLDZELDA0.07579.31M
SCUSTEMCELL UNITED-0.00284900284915.40M
RGIROTO-GRO-0.012658227848132.68M
QBLQUEENSLAND BAUXITE-0.25925925925963.75M
MMJMMJ PHYTOTECH-0.19780219780279.52M
MXCMGC PHARMA-0.075268817204395.03M
MDCMEDLAB CLINICAL-0.214285714286131.05M
LSHLIFESPOT HEALTH0.038461538461510.87M
THCHYDROPONICS-0.21582733812968.64M
EVEEVE INVESTMENTS-0.33333333333321.99M
ESEESENSE-LAB-0.43103448275913.31M
EXLELIXINOL GLOBAL (*floated Jan 2018)0.71174.98M
CPHCRESO PHARMA-0.19354838709783.22M
CP1CANNPAL ANIMAL0.097560975609821.88M
CANCANN GROUP0.0454545454545429.80M
BOTBOTANIX PHARMACE0.61764705882478.42M
BDABOD AUSTRALIA-0.012820512820520.45M
AC8AUSCANN GROUP0.968944099379437.96M
ATPATLAS PEARLS-0.14814814814810.27M
AEBALGAE.TEC019.87M
1PG1-PAGE025M

 

This article first appeared on Business Insider Australia, Australia’s most popular business news website. Read the original article. Follow Business Insider on Facebook or Twitter.